# ALX Oncology (ALXO) — Earnings

ALXO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/alxo/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2026 |
| Period end | Mar 31, 2026 |
| EPS actual | −$0.17 |
| EPS estimate | −$0.19 |
| EPS surprise | +9.53% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | May 8, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1810182/000119312526213399/alxo-20260331.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/0b9ed255-ff5b-9608-e6c1-8ed328c4a14b.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2026 | May 8, 2026 | −$0.19 | −$0.17 | 9.53% | — | — |
| Q4 2025 | Feb 27, 2026 | −$0.40 | −$0.42 | -5.00% | — | — |
| Q3 2025 | Nov 7, 2025 | −$0.37 | −$0.41 | -11.81% | — | — |
| Q2 2025 | Aug 12, 2025 | −$0.42 | −$0.49 | -16.11% | — | — |
| Q1 2025 | May 8, 2025 | −$0.46 | −$0.58 | -25.05% | — | — |
| Q4 2024 | Mar 6, 2025 | −$0.67 | −$0.55 | 17.91% | — | — |
| Q3 2024 | Nov 7, 2024 | −$0.78 | −$0.58 | 25.64% | — | — |
| Q2 2024 | Aug 8, 2024 | −$0.75 | −$0.76 | -1.56% | — | — |
| Q1 2024 | May 9, 2024 | −$0.82 | −$0.71 | 13.12% | — | — |
| Q4 2023 | Mar 7, 2024 | −$0.88 | −$0.93 | -6.08% | — | — |
| Q3 2023 | Nov 13, 2023 | −$0.85 | −$1.24 | -45.54% | — | — |
| Q2 2023 | Aug 10, 2023 | −$0.88 | −$0.84 | 4.55% | — | — |
| Q1 2023 | May 11, 2023 | −$0.80 | −$0.74 | 7.80% | — | — |
| Q4 2022 | Mar 9, 2023 | −$0.89 | −$0.75 | 15.38% | — | — |
| Q3 2022 | Nov 8, 2022 | −$0.77 | −$0.87 | -12.50% | — | — |
| Q2 2022 | Aug 8, 2022 | −$0.63 | −$0.81 | -27.84% | — | — |
| Q1 2022 | May 9, 2022 | −$0.71 | −$0.60 | 15.75% | — | — |
| Q4 2021 | Feb 28, 2022 | −$0.61 | −$0.70 | -14.45% | — | — |
| Q3 2021 | Nov 12, 2021 | −$0.48 | −$0.61 | -28.21% | — | — |
| Q2 2021 | Aug 12, 2021 | −$0.44 | −$0.40 | 8.36% | $105,400.00 | — |

## Frequently Asked Questions

### When did ALX Oncology (ALXO) last report earnings?

ALX Oncology last reported on May 8, 2026, covering fiscal Q1 2026.

### Did ALXO beat earnings estimates?

Yes. ALX Oncology reported EPS of −$0.17 for Q1 2026 against a −$0.19 estimate — a 9.53% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).